β-Carboline-based molecular hybrids as anticancer agents: a brief sketch

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Oncology

Background:

• Cancer poses a significant global health burden and mortality risk.
• Chemotherapy is crucial for cancer treatment, but faces challenges like drug resistance and adverse effects.
• Development of novel chemotherapeutic agents is essential to overcome current limitations.

Purpose of the Study:

• To review the development of beta-carboline-based chemotherapeutic agents over the past five years.
• To focus on molecular hybrids of beta-carbolines with various pharmacophores.
• To present synthetic strategies, in vitro anticancer evaluation, and mechanisms of action.

Main Methods:

• Literature review of beta-carboline derivatives and their anticancer properties.
• Analysis of synthetic routes for beta-carboline molecular hybrids.
• Evaluation of in vitro anticancer activity and in silico studies.

Main Results:

• Diverse molecular hybrids of beta-carbolines with various pharmacophores have been synthesized.
• In vitro studies demonstrate anticancer potential against various cancer cell lines.
• Structure-activity relationships and mechanisms of action have been elucidated.

Conclusions:

• Beta-carboline molecular hybrids represent a promising class of novel chemotherapeutic agents.
• Understanding structural features is key to developing potent and selective anticancer drugs.
• This review provides insights for future development of effective cytotoxic agents.